Livforsakringsbolaget Skandia, Omsesidigt Regeneron Pharmaceuticals, Inc. Transaction History
Livforsakringsbolaget Skandia, Omsesidigt
- $1.73 Billion
- Q1 2025
A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 11,332 shares of REGN stock, worth $6.2 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
11,332
Previous 11,332
-0.0%
Holding current value
$6.2 Million
Previous $8.07 Million
10.96%
% of portfolio
0.41%
Previous 0.44%
Shares
25 transactions
Others Institutions Holding REGN
# of Institutions
1,472Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.15 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.62 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.1 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.62 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.18 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $58.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...